DrugPatentWatch Database Preview
Breckenridge Company Profile
» See Plans and Pricing
What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?
BRECKENRIDGE has forty-five approved drugs.
There are three tentative approvals on BRECKENRIDGE drugs.
Summary for Breckenridge
| US Patents: | 0 |
| Tradenames: | 40 |
| Ingredients: | 40 |
| NDAs: | 45 |
| Patent Litigation for Breckenridge: | See patent lawsuits for Breckenridge |
| PTAB Cases with Breckenridge as petitioner: | See PTAB cases with Breckenridge as petitioner |
Drugs and US Patents for Breckenridge
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breckenridge | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 212638-001 | Oct 9, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Breckenridge | ENTECAVIR | entecavir | TABLET;ORAL | 208721-001 | Mar 15, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Breckenridge | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 209063-002 | Nov 26, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Breckenridge | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 205990-002 | Feb 8, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Breckenridge | PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 078472-002 | Feb 13, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Breckenridge | LANSOPRAZOLE | lansoprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 203964-002 | Oct 17, 2018 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
